Acute lipodermatosclerosis: An open clinical trial of stanozolol in patients unable to sustain compression therapy

Dermatology Online Journal

Volumn 14, Issue 2, 2008, Pages

  Akovi, Z ^a   Vesi, S ^a   Vukovi, J ^a   Medenica, L J ^a   Pavlovi, M D ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

STANOZOLOL;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPODERMATOSCLEROSIS; MALE; PAIN ASSESSMENT; SKINFOLD THICKNESS; VEIN INSUFFICIENCY; COMPRESSION GARMENT; ECHOGRAPHY; LOCALIZED SCLERODERMA; MIDDLE AGED; PAIN; PANNICULITIS; PATHOLOGY; PATHOPHYSIOLOGY; SAPHENOUS VEIN; SKIN; TREATMENT REFUSAL;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PANNICULITIS; SAPHENOUS VEIN; SCLERODERMA, LOCALIZED; SKIN; STANOZOLOL; STOCKINGS, COMPRESSION; TREATMENT REFUSAL; VENOUS INSUFFICIENCY;

EID: 41149163621     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993 Apr;28(4):623-7.
2. Greenberg AS, Hasan A, Montalvo BM, Falabella A, Falanga V. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol. 1996 Oct;35(4):566-8.
3. Gniadecka M. Localization of dermal edema in lipodermatosclerosis, lymphedema, and cardiac insufficiency. High-frequency ultrasound examination of intradermal echogenicity. J Am Acad Dermatol. 1996 Jul;35 (1):37-41.
4. Bull RH, Mortimer PS. Acute lipodermatosclerosis in a pendulous abdomen. Clin Exp Dermatol. 1993 Mar;18(2):164-6.
5. Howlader MH, Smith PD. Microangiopathy in chronic venous insufficiency: quantitative assessment by capillary microscopy. Eur J Vasc Endovasc Surg. 2003 Sep;26(3):325-31.
6. Burnard K, Clemenson G, Morland M, Jarrett PEM, Browse NL. Venous lipodermatosclerosis, treatment by fibrinolytic enhancement and elastic compression. Br Med J. 1980 Jan 5;280(6206):7-11.
7. Helfman T, FalangaV. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):254-8.
8. McMullin GM, Watkin GT, Coleridge Smith PD, Scurr JH. Efficacy of fibrinolytic enhancement with stanozolol in treatment of venous insufficiency. Aust N Z J Surg. 1991 Apr;61(4):306-9.
9. Kendrick DB, Strout TD. The minimum clinically significant difference in patient-assigned numeric scores for pain. Am J Emerg Med. 2005 Nov;23 (7):828-32.
10. Ryan TJ, Burnard KG. Diseases of the veins and arteries: leg ulcers. In: Rook et al. Textbook of Dermatology, 6th ed, eds: Champion RH et al, Blackwell, Oxford, 1998: 2228-76.
11. Requena L, Yus ES. Panniculitis. Part II Mostly lobular panniculitis. J Am Acad Dermatol. 2001 Sep;45(3):325-61.
12. Peschen M, Rogers MM, Chen WY, et al. Modulation of urokinase type and tissue type plasminogen activator occurs at an early stage of progressing stages of chronic venous insufficiency. Acta Derm Venereol. 2000 May;80 (3):162-6.
13. Yosipovitch G, Mengesha Y, Facliaru D. Topical capsaicin for the treatment of acute lipodermatosclerosis and lobular panniculitis. J Dermatolog Treat. 2005 Aug;16(3):178-80.
14. Hafner C, Wimmershoff M, Landthaler M, Vogt T. Lipodermatosclerosis: successful treatment with danazol. Acta Derm Venereol. 2005;85(4):365-6.
15. Bruce AJ, Bennett DD, Lohse CM, Rooke TW, Davis MDP. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol. 2002 Feb;46(2):187-92.